TITLE

A Mouse Monoclonal Antibody against Epstein-Barr Virus Envelope Glycoprotein 350 Prevents Infection Both In Vitro and In Vivo

AUTHOR(S)
Haque, Tanzina; Johannessen, Ingolfur; Dombagoda, Dilani; Sengupta, Chandrya; Burns, David M.; Bird, Pru; Hale, Geoff; Mieli-Vergani, Giorgina; Crawford, Dorothy H.
PUB. DATE
September 2006
SOURCE
Journal of Infectious Diseases;9/1/2006, Vol. 194 Issue 5, p584
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A mouse monoclonal antibody (MAb) against Epstein-Barr virus (EBV) envelope glycoprotein 350, 72A1, inhibited EBV infection of B lymphocytes in vitro. When severe combined immunodeficient mice were injected with EBV-seronegative donors' peripheral-blood mononuclear cells and challenged with EBV, 72A1 MAb prevented development of EBV-positive tumors: none of the test mice (0/12) developed EBV-positive tumors. In contrast, 67% (8/12) of control mice developed EBV-positive tumors (P = .001 ). Purified 72A1 MAb was infused into 1 healthy adult and 4 EBV-seronegative children after liver transplant. No adverse reactions were seen in the adult or in 3 of the transplant recipients. The remaining patient developed a hypersensitivity reaction, thus underlining the need to humanize the MAb.
ACCESSION #
21900574

 

Related Articles

  • DNA-mediated Immunization of Glycoprotein 350 of Epsteln-Barr Virus Induces the Effective Humoral and Cellular Immune Responses Against the Antigen. Sojin Jung; Young-Kwan Chung; Sun-Hwa Chang; Ju Kim; Hak-Ryul Kim; Hyon-Seok Jang; Jeong-Chae Lee; Gook-Hyun Chung; Yong-Suk Jang // Molecules & Cells (Springer Science & Business Media B.V.);2001, Vol. 12 Issue 1, p41 

    Epstein-Barr virus (EBV) is a human pathogen that is involved in numerous diseases and tumors. Since the EBV infection occurs in the early ages of life, and most of the population is subsequently exposed to EBV, the conventional method of vaccination to induce the prophylactic immunity cannot be...

  • Structure of the Epstein-Barr virus major envelope glycoprotein. Szakonyi, Gerda; Klein, Michael G.; Hannan, Jonathan P.; Young, Kendra A.; Ma, Runlin Z.; Asokan, Rengasamy; Holers, V. Michael; Chen, Xiaojiang S. // Nature Structural & Molecular Biology;Nov2006, Vol. 13 Issue 11, p996 

    Epstein-Barr virus (EBV) infection of B cells is associated with lymphoma and other human cancers. EBV infection is initiated by the binding of the viral envelope glycoprotein (gp350) to the cell surface receptor CR2. We determined the X-ray structure of the highly glycosylated gp350 and defined...

  • Characteristics of Epstein—Barr virus envelope protein gp42. Shaw, Pamela L.; Kirschner, Austin N.; Jardetzky, Theodore S.; Longnecker, Richard // Virus Genes;Jun2010, Vol. 40 Issue 3, p307 

    Epstein–Barr virus (EBV) glycoprotein 42 (gp42) is a membrane protein essential for fusion and entry of EBV into host B-lymphocytes. Gp42 is a member of the protein-fold family C-type lectin or lectin-like domains (CLECT or CTLD) and specifically is classified as a natural-killer receptor...

  • Immunoscintigraphy of metastases with radiolabelled human antibodies. Al-Azzawi, F.; Smith, J.; Stimson, W.H. // British Medical Journal (Clinical Research Edition);2/28/1987, Vol. 294 Issue 6571, p545 

    Examines the production of a lymphoblastoid cell line by the transformation of lymph node lymphocytes. Selection of antibody secreting clones by testing the supernatants of lymphoblastoid cells; Use of human antibody to assess the extent of a growth in a patient with secondary disease;...

  • Chronicity of Epstein-Barr Virus Infection. Niederman, James C. // Annals of Internal Medicine;Jan85, Vol. 102 Issue 1, p119 

    Editorial. Talks about the identification of the etiologic role of Epstein-Barr virus. Results of bioassays based on lymphocyte immortalization; Limitations of the use of anti-early antigen levels as a discriminator of active infection; Implication of the recognition of the complex lifelong...

  • Hodgkin Lymphoma-Associated Hemophagocytic Syndrome: A Disorder Strongly Correlated with Epstein-Barr Virus. Ménard,1,2,3, Fanny; Besson, Caroline; Rincé, Patricia; Lambotte, Olivier; Lazure, Thierry; Canioni, Danielle; Hermine, Olivier; Brousset, Pierre; Martin, Antoine; Gaulard, Philippe; Raphaël, Martine; Larroche, Claire // Clinical Infectious Diseases;8/15/2008, Vol. 47 Issue 4, p531 

    The retrospective study of 34 patients with Hodgkin lymphoma- associated hemophagocytic syndrome led us to define this association as a specific disorder. Its characteristics are male predominance (male-to-female sex ratio, 3.3:1), immunodeficiency- like histological features (lymphocyte...

  • Coronin-1A: Immune Deficiency in Humans and Mice. Punwani, Divya; Pelz, Barry; Yu, Jason; Arva, Nicoleta; Schafernak, Kristian; Kondratowicz, Karly; Makhija, Melanie; Puck, Jennifer // Journal of Clinical Immunology;Feb2015, Vol. 35 Issue 2, p100 

    No abstract available.

  • Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases Okano, M.; Purtilo, D. T.; Grierson, H. L. // Environmental Health Perspectives;Aug1990, Vol. 88, p225 

    No abstract available.

  • Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1. Eden, Emily R.; Patel, Dilipkumar D.; Xi-Ming Sun; Burden, Jemima J.; Themis, Michael; Edwards, Matthew; Lee, Philip; Neuwirth, Clare; Naoumova, Rossitza P.; Soutar, Anne K.; Sun, Xi-Ming // Journal of Clinical Investigation;12/1/2002, Vol. 110 Issue 11, p1695 

    Familial hypercholesterolemia is an autosomal dominant disorder with a gene-dosage effect that is usually caused by mutations in the LDL receptor gene that disrupt normal clearance of LDL. In the homozygous form, it results in a distinctive clinical phenotype, characterized by inherited...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics